Meeder Asset Management’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-454
| Closed | -$9.08K | – | 901 |
|
|
2024
Q3 | $9.08K | Buy |
+454
| New | +$9.08K | ﹤0.01% | 639 |
|
|
2021
Q4 | – | Sell |
-1,008
| Closed | -$1K | – | 1109 |
|
|
2021
Q3 | $1K | Hold |
1,008
| – | – | ﹤0.01% | 2268 |
|
|
2021
Q2 | $2K | Hold |
1,008
| – | – | ﹤0.01% | 2175 |
|
|
2021
Q1 | $1K | Buy |
+1,008
| New | +$1K | ﹤0.01% | 2164 |
|
|
2020
Q2 | – | Sell |
-2,202
| Closed | -$6K | – | 2014 |
|
|
2020
Q1 | $6K | Buy |
2,202
+710
| +48% | +$1.94K | ﹤0.01% | 1695 |
|
|
2019
Q4 | $6K | Sell |
1,492
-30
| -2% | -$121 | ﹤0.01% | 1700 |
|
|
2019
Q3 | $7K | Buy |
1,522
+233
| +18% | +$1.07K | ﹤0.01% | 1628 |
|
|
2019
Q2 | $5K | Buy |
1,289
+303
| +31% | +$1.18K | ﹤0.01% | 1648 |
|
|
2019
Q1 | $4K | Buy |
986
+157
| +19% | +$637 | ﹤0.01% | 1424 |
|
|
2018
Q4 | $2K | Sell |
829
-251
| -23% | -$606 | ﹤0.01% | 1557 |
|
|
2018
Q3 | $7K | Buy |
1,080
+684
| +173% | +$4.43K | ﹤0.01% | 1233 |
|
|
2018
Q2 | $1.79K | Buy |
+396
| New | +$1.79K | ﹤0.01% | 1430 |
|